Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 1
2005 5
2006 7
2007 1
2008 1
2009 11
2010 16
2011 11
2012 21
2013 18
2014 14
2015 20
2016 16
2017 26
2018 17
2019 14
2020 14
2021 16
2022 14
2023 23
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

255 results

Results by year

Filters applied: . Clear all
Page 1
Protective mucosal SARS-CoV-2 antibodies in the majority of the general population in the Netherlands.
Verheul MK, Kaczorowska J, Hofstee MI, Schepp RM, Smits GP, Wessels Beljaars D, Kuijer M, Schuin W, Middelhof I, Wong D, van Hagen CCE, Vos ERA, Nicolaie MA, de Melker HE, van Binnendijk RS, van der Klis FRM, den Hartog G. Verheul MK, et al. Among authors: de melker he. Mucosal Immunol. 2024 Mar 27:S1933-0219(24)00027-8. doi: 10.1016/j.mucimm.2024.03.008. Online ahead of print. Mucosal Immunol. 2024. PMID: 38553008 Free article.
Health-related quality of life during the COVID-19 pandemic: The impact of restrictive measures using data from two Dutch population-based cohort studies.
van Hagen CCE, Huiberts AJ, Mutubuki EN, de Melker HE, Vos ERA, van de Wijgert JHHM, van den Hof S, Knol MJ, van Hoek AJ. van Hagen CCE, et al. Among authors: de melker he. PLoS One. 2024 Mar 18;19(3):e0300324. doi: 10.1371/journal.pone.0300324. eCollection 2024. PLoS One. 2024. PMID: 38498510 Free PMC article.
Effectiveness of Omicron XBB.1.5 vaccine against infection with SARS-CoV-2 Omicron XBB and JN.1 variants, prospective cohort study, the Netherlands, October 2023 to January 2024.
Huiberts AJ, Hoeve CE, de Gier B, Cremer J, van der Veer B, de Melker HE, van de Wijgert JH, van den Hof S, Eggink D, Knol MJ. Huiberts AJ, et al. Among authors: de melker he. Euro Surveill. 2024 Mar;29(10):2400109. doi: 10.2807/1560-7917.ES.2024.29.10.2400109. Euro Surveill. 2024. PMID: 38456217 Free PMC article.
255 results